New ALS drug trial launches: hope for slowing the disease?
Disease control
Recruiting now
This early-stage study tests a new drug called VTx-002 in 12 people with ALS. The main goal is to check if the drug is safe and tolerable when given as a single injection into the fluid around the brain and spinal cord. Researchers will also look for signs that the drug might slo…
Phase: PHASE1, PHASE2 • Sponsor: Vector Y Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC